Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Oncology Biomarker Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncology Biomarker Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncology Biomarker Overall Market Size
2.1 Global Oncology Biomarker Market Size: 2021 VS 2028
2.2 Global Oncology Biomarker Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oncology Biomarker Players in Global Market
3.2 Top Global Oncology Biomarker Companies Ranked by Revenue
3.3 Global Oncology Biomarker Revenue by Companies
3.4 Top 3 and Top 5 Oncology Biomarker Companies in Global Market, by Revenue in 2021
3.5 Global Companies Oncology Biomarker Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncology Biomarker Players in Global Market
3.6.1 List of Global Tier 1 Oncology Biomarker Companies
3.6.2 List of Global Tier 2 and Tier 3 Oncology Biomarker Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Oncology Biomarker Market Size Markets, 2021 & 2028
4.1.2 Lung Cancer
4.1.3 Breast Cancer
4.1.4 Colorectal Cancer
4.1.5 Prostate Cancer
4.1.6 Stomach Cancer
4.1.7 Others
4.2 By Type - Global Oncology Biomarker Revenue & Forecasts
4.2.1 By Type - Global Oncology Biomarker Revenue, 2017-2022
4.2.2 By Type - Global Oncology Biomarker Revenue, 2023-2028
4.2.3 By Type - Global Oncology Biomarker Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oncology Biomarker Market Size, 2021 & 2028
5.1.2 Diagnostics
5.1.3 Drug Discovery And Development
5.1.4 Prognostics
5.1.5 Risk Assessment
5.1.6 Others
5.2 By Application - Global Oncology Biomarker Revenue & Forecasts
5.2.1 By Application - Global Oncology Biomarker Revenue, 2017-2022
5.2.2 By Application - Global Oncology Biomarker Revenue, 2023-2028
5.2.3 By Application - Global Oncology Biomarker Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Oncology Biomarker Market Size, 2021 & 2028
6.2 By Region - Global Oncology Biomarker Revenue & Forecasts
6.2.1 By Region - Global Oncology Biomarker Revenue, 2017-2022
6.2.2 By Region - Global Oncology Biomarker Revenue, 2023-2028
6.2.3 By Region - Global Oncology Biomarker Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Oncology Biomarker Revenue, 2017-2028
6.3.2 US Oncology Biomarker Market Size, 2017-2028
6.3.3 Canada Oncology Biomarker Market Size, 2017-2028
6.3.4 Mexico Oncology Biomarker Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Oncology Biomarker Revenue, 2017-2028
6.4.2 Germany Oncology Biomarker Market Size, 2017-2028
6.4.3 France Oncology Biomarker Market Size, 2017-2028
6.4.4 U.K. Oncology Biomarker Market Size, 2017-2028
6.4.5 Italy Oncology Biomarker Market Size, 2017-2028
6.4.6 Russia Oncology Biomarker Market Size, 2017-2028
6.4.7 Nordic Countries Oncology Biomarker Market Size, 2017-2028
6.4.8 Benelux Oncology Biomarker Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Oncology Biomarker Revenue, 2017-2028
6.5.2 China Oncology Biomarker Market Size, 2017-2028
6.5.3 Japan Oncology Biomarker Market Size, 2017-2028
6.5.4 South Korea Oncology Biomarker Market Size, 2017-2028
6.5.5 Southeast Asia Oncology Biomarker Market Size, 2017-2028
6.5.6 India Oncology Biomarker Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Oncology Biomarker Revenue, 2017-2028
6.6.2 Brazil Oncology Biomarker Market Size, 2017-2028
6.6.3 Argentina Oncology Biomarker Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oncology Biomarker Revenue, 2017-2028
6.7.2 Turkey Oncology Biomarker Market Size, 2017-2028
6.7.3 Israel Oncology Biomarker Market Size, 2017-2028
6.7.4 Saudi Arabia Oncology Biomarker Market Size, 2017-2028
6.7.5 UAE Oncology Biomarker Market Size, 2017-2028
7 Players Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Oncology Biomarker Major Product Offerings
7.1.4 Abbott Laboratories Oncology Biomarker Revenue in Global Market (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Corporate Summary
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb Oncology Biomarker Major Product Offerings
7.2.4 Bristol-Myers Squibb Oncology Biomarker Revenue in Global Market (2017-2022)
7.2.5 Bristol-Myers Squibb Key News
7.3 Eli Lilly and Company
7.3.1 Eli Lilly and Company Corporate Summary
7.3.2 Eli Lilly and Company Business Overview
7.3.3 Eli Lilly and Company Oncology Biomarker Major Product Offerings
7.3.4 Eli Lilly and Company Oncology Biomarker Revenue in Global Market (2017-2022)
7.3.5 Eli Lilly and Company Key News
7.4 F.Hoffmann-La Roche Ltd.
7.4.1 F.Hoffmann-La Roche Ltd. Corporate Summary
7.4.2 F.Hoffmann-La Roche Ltd. Business Overview
7.4.3 F.Hoffmann-La Roche Ltd. Oncology Biomarker Major Product Offerings
7.4.4 F.Hoffmann-La Roche Ltd. Oncology Biomarker Revenue in Global Market (2017-2022)
7.4.5 F.Hoffmann-La Roche Ltd. Key News
7.5 Genomic Health
7.5.1 Genomic Health Corporate Summary
7.5.2 Genomic Health Business Overview
7.5.3 Genomic Health Oncology Biomarker Major Product Offerings
7.5.4 Genomic Health Oncology Biomarker Revenue in Global Market (2017-2022)
7.5.5 Genomic Health Key News
7.6 GlaxoSmithKline plc
7.6.1 GlaxoSmithKline plc Corporate Summary
7.6.2 GlaxoSmithKline plc Business Overview
7.6.3 GlaxoSmithKline plc Oncology Biomarker Major Product Offerings
7.6.4 GlaxoSmithKline plc Oncology Biomarker Revenue in Global Market (2017-2022)
7.6.5 GlaxoSmithKline plc Key News
7.7 Novartis AG
7.7.1 Novartis AG Corporate Summary
7.7.2 Novartis AG Business Overview
7.7.3 Novartis AG Oncology Biomarker Major Product Offerings
7.7.4 Novartis AG Oncology Biomarker Revenue in Global Market (2017-2022)
7.7.5 Novartis AG Key News
7.8 Merck & Co.
7.8.1 Merck & Co. Corporate Summary
7.8.2 Merck & Co. Business Overview
7.8.3 Merck & Co. Oncology Biomarker Major Product Offerings
7.8.4 Merck & Co. Oncology Biomarker Revenue in Global Market (2017-2022)
7.8.5 Merck & Co. Key News
7.9 Pfizer
7.9.1 Pfizer Corporate Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Oncology Biomarker Major Product Offerings
7.9.4 Pfizer Oncology Biomarker Revenue in Global Market (2017-2022)
7.9.5 Pfizer Key News
7.10 Qiagen N.V.
7.10.1 Qiagen N.V. Corporate Summary
7.10.2 Qiagen N.V. Business Overview
7.10.3 Qiagen N.V. Oncology Biomarker Major Product Offerings
7.10.4 Qiagen N.V. Oncology Biomarker Revenue in Global Market (2017-2022)
7.10.5 Qiagen N.V. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer